Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario G Pavez-Giani

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Cell and Developmental Biology|January 27, 2022
Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem CellsMario G Pavez-Giani, Lukas Cyganek
Journal of Internal Medicine|February 9, 2022
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?Nils Bomer, Mario G Pavez-Giani, Niels Grote Beverborg, et al.
European Journal of Heart Failure|April 30, 2019
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarctionSalva R Yurista, Herman H W Silljé, Silke U Oberdorf-Maass, et al.
International Journal of Molecular Sciences|November 13, 2021
Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human CardiomyocytesNils Bomer, Mario G Pavez-Giani, Frederik E Deiman, et al.
The Journal of Clinical Investigation|July 22, 2021
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissuesMathilde Csc Vermeer, Maria C Bolling, Jacqueline M Bliley, et al.
Pflugers Archiv : European Journal of Physiology|June 18, 2021
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exerciseKirsten T Nijholt, Laura M G Meems, Willem P T Ruifrok, et al.
International Journal of Molecular Sciences|April 30, 2021
ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca<sup>2+</sup> Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδMario G Pavez-Giani, Pablo I Sánchez-Aguilera, Nils Bomer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Cell and Developmental Biology|January 27, 2022
Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem CellsMario G Pavez-Giani, Lukas Cyganek
Journal of Internal Medicine|February 9, 2022
Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?Nils Bomer, Mario G Pavez-Giani, Niels Grote Beverborg, et al.
European Journal of Heart Failure|April 30, 2019
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarctionSalva R Yurista, Herman H W Silljé, Silke U Oberdorf-Maass, et al.
International Journal of Molecular Sciences|November 13, 2021
Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human CardiomyocytesNils Bomer, Mario G Pavez-Giani, Frederik E Deiman, et al.
The Journal of Clinical Investigation|July 22, 2021
Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissuesMathilde Csc Vermeer, Maria C Bolling, Jacqueline M Bliley, et al.
Pflugers Archiv : European Journal of Physiology|June 18, 2021
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exerciseKirsten T Nijholt, Laura M G Meems, Willem P T Ruifrok, et al.
International Journal of Molecular Sciences|April 30, 2021
ATPase Inhibitory Factor-1 Disrupts Mitochondrial Ca<sup>2+</sup> Handling and Promotes Pathological Cardiac Hypertrophy through CaMKIIδMario G Pavez-Giani, Pablo I Sánchez-Aguilera, Nils Bomer, et al.
Pageof 1